Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 38, Issue 13, Pages 4274-4284
Publisher
Oxford University Press (OUP)
Online
2010-03-23
DOI
10.1093/nar/gkq174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
- (2010) John S. Albin et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- APOBEC3 proteins mediate the clearance of foreign DNA from human cells
- (2010) Mark D Stenglein et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS
- (2009) Judd F Hultquist et al. Future Virology
- The Range of Human APOBEC3H Sensitivity to Lentiviral Vif Proteins
- (2009) M. M. H. Li et al. JOURNAL OF VIROLOGY
- Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
- (2009) F. A. Koning et al. JOURNAL OF VIROLOGY
- Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G
- (2009) Michel Henry et al. PLoS One
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
- (2009) F. K. Swirski et al. SCIENCE
- CEM-T4 Cells Do Not Lack an APOBEC3G Cofactor
- (2009) Guylaine Haché et al. PLoS Pathogens
- Differences in APOBEC3G Expression in CD4+ T Helper Lymphocyte Subtypes Modulate HIV-1 Infectivity
- (2009) Michael L. Vetter et al. PLoS Pathogens
- Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
- (2009) Iñigo Narvaiza et al. PLoS Pathogens
- The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements
- (2008) Ya-Lin Chiu et al. Annual Review of Immunology
- The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals
- (2008) Rebecca S LaRue et al. BMC MOLECULAR BIOLOGY
- HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
- (2008) Michael H. Malim et al. Cell Host & Microbe
- Antiretroelement Activity of APOBEC3H Was Lost Twice in Recent Human Evolution
- (2008) Molly OhAinle et al. Cell Host & Microbe
- Evolution of HIV-1 Isolates that Use a Novel Vif-Independent Mechanism to Resist Restriction by Human APOBEC3G
- (2008) Guylaine Haché et al. CURRENT BIOLOGY
- Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1
- (2008) Lindi Tan et al. FASEB JOURNAL
- Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication
- (2008) Ying Dang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells
- (2008) F.-x. Wang et al. JOURNAL OF GENERAL VIROLOGY
- Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H
- (2008) J. Kock et al. JOURNAL OF GENERAL VIROLOGY
- Hypermutation of an Ancient Human Retrovirus by APOBEC3G
- (2008) Y. N. Lee et al. JOURNAL OF VIROLOGY
- Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H
- (2008) A. Harari et al. JOURNAL OF VIROLOGY
- HIV-1 Vif, APOBEC, and Intrinsic Immunity
- (2008) Ritu Goila-Gaur et al. Retrovirology
- Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions
- (2008) J.-P. Vartanian et al. SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started